Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?

Abstract Background: Chronic Spontaneous Urticaria (CSU) is characterized by recurrent wheals and/or angioedema for longer than 6-weeks. Guidelines recommend Omalizumab (Oma) as first-line and Cyclosporine-A (Cs-A) as second-line treatment in antihistamine resistant CSU. This step-wise algorithm mig...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Emek Kocatürk (Autor), Emel Bülbül Başkan (Autor), Özlem Su Küçük (Autor), Mustafa Özdemir (Autor), Sinem Örnek (Autor), Pelin Kuteyla Can (Autor), Eda Hașal (Autor), Burhan Engin (Autor), Nilgün Atakan (Autor), Erkan Alpsoy (Autor)
Formato: Libro
Publicado: Sociedade Brasileira de Dermatologia, 2022-09-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible